Bromide

Bromide

SCHEMBL1732147

Br.CCOc1cc2c(c(F)c1OCC)C(=N)N(CC(=O)c1ccc(OC(=O)N3CCCC3)c(C(C)(C)C)c1)C2

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
F2R P25116 6/20 0.62
SMN1; SMN2 Q16637 2/20 0.37
GAA P10253 1/20 0.37
KMT2A Q03164 2/20 0.35
HPGD P15428 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LMNA P02545 3/20 0.33
MAPT P10636 2/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.33
NPSR1 Q6W5P4 2/20 0.33
MEN1 O00255 1/20 0.33
KDM4E B2RXH2 2/20 0.33
RAB9A P51151 2/20 0.33
NPC1 O15118 1/20 0.33
GLA P06280 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL1730529 0.91 F2R (0.64) F2RSMN1; SMN2KMT2ALMNAMAPT
SCHEMBL6544433 0.90 F2R (0.64) F2RSMN1; SMN2KMT2ALMNAMAPT
Bromide SCHEMBL1731125 0.89 F2R (0.54) F2RSMN1; SMN2KMT2AHPGDL3MBTL1
Bromide SCHEMBL1730629 0.88 F2R (0.61) F2RLMNAMAPTKDM4ERAB9A
Bromide SCHEMBL1729491 0.88 F2R (0.61) F2RLMNAMAPTKDM4ERAB9A
Bromide SCHEMBL1731874 0.88 F2R (0.70) F2RSMN1; SMN2GAAKMT2AHPGD
Bromide SCHEMBL1730193 0.86 F2R (0.66) F2RSMN1; SMN2MAPTKDM4ERAB9A
Bromide SCHEMBL1731057 0.86 F2R (0.62) F2RSMN1; SMN2LMNAMAPTKDM4E
Bromide SCHEMBL1729476 0.86 F2R (0.62) F2RLMNAMAPTALDH1A1KDM4E
Bromide SCHEMBL1729942 0.86 F2R (0.65) F2RLMNAMAPTPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1391451-B1 2-IMINOPYRROLIDINE DERIVATES EISAI R&D MAN CO LTD (JP) 2011-11-23 EP disclosed
US-7244730-B2 2-iminopyrrolidine derivatives EISAI CO., LTD (JP) 2007-07-17 US disclosed
US-20050245592-A1 2-Iminopyrrolidine derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-03 US disclosed
US-20050004204-A1 2-Iminopyrrolidine derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-01-06 US disclosed
EP-1391451-A1 2-IMINOPYRROLIDINE DERIVATES Eisai Co., Ltd. (JP) 2004-02-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245592-A1 2-Iminopyrrolidine derivatives H1-2, H1-3, H1-0 F2R 2290/4885SMN1; SMN2 2355/4885GAA 4867/4885
US-20050004204-A1 2-Iminopyrrolidine derivatives H1-2, H1-3, H1-0 F2R 2289/4885SMN1; SMN2 2369/4885GAA 4868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.